These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37257818)

  • 1. Genetic code expansion in E. coli enables production of a functional 'ready-to-click' T cell receptor-specific scFv.
    Pasupuleti R; Rosato F; Kolanovic D; Makshakova ON; Römer W; Wiltschi B
    N Biotechnol; 2023 Sep; 76():127-137. PubMed ID: 37257818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive properties of anti-CD3 single-chain Fv and diabody.
    Le Gall F; Reusch U; Moldenhauer G; Little M; Kipriyanov SM
    J Immunol Methods; 2004 Feb; 285(1):111-27. PubMed ID: 14871540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetically Encoded Azide Containing Amino Acid in Mammalian Cells Enables Site-Specific Antibody-Drug Conjugates Using Click Cycloaddition Chemistry.
    VanBrunt MP; Shanebeck K; Caldwell Z; Johnson J; Thompson P; Martin T; Dong H; Li G; Xu H; D'Hooge F; Masterson L; Bariola P; Tiberghien A; Ezeadi E; Williams DG; Hartley JA; Howard PW; Grabstein KH; Bowen MA; Marelli M
    Bioconjug Chem; 2015 Nov; 26(11):2249-60. PubMed ID: 26332743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-free production of Gaussia princeps luciferase--antibody fragment bioconjugates for ex vivo detection of tumor cells.
    Patel KG; Ng PP; Kuo CC; Levy S; Levy R; Swartz JR
    Biochem Biophys Res Commun; 2009 Dec; 390(3):971-6. PubMed ID: 19852937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two amino acid mutations in an anti-human CD3 single chain Fv antibody fragment that affect the yield on bacterial secretion but not the affinity.
    Kipriyanov SM; Moldenhauer G; Martin AC; Kupriyanova OA; Little M
    Protein Eng; 1997 Apr; 10(4):445-53. PubMed ID: 9194170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy based on bispecific T-cell engager with hIgG1 Fc sequence as a new therapeutic strategy in multiple myeloma.
    Zou J; Chen D; Zong Y; Ye S; Tang J; Meng H; An G; Zhang X; Yang L
    Cancer Sci; 2015 May; 106(5):512-21. PubMed ID: 25664501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lectin-anticancer peptide fusion demonstrates a significant cancer-cell-selective cytotoxic effect and inspires the production of "clickable" anticancer peptide in Escherichia coli.
    Pasupuleti R; Riedl S; Saltor Núñez L; Karava M; Kumar V; Kourist R; Turnbull WB; Zweytick D; Wiltschi B
    Protein Sci; 2023 Dec; 32(12):e4830. PubMed ID: 37916438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humanized OKT3 antibodies: successful transfer of immune modulating properties and idiotype expression.
    Woodle ES; Thistlethwaite JR; Jolliffe LK; Zivin RA; Collins A; Adair JR; Bodmer M; Athwal D; Alegre ML; Bluestone JA
    J Immunol; 1992 May; 148(9):2756-63. PubMed ID: 1533410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Full-length recombinant antibodies from
    Rashid MH
    MAbs; 2022; 14(1):2111748. PubMed ID: 36018829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineering Antibodies with C-Terminal Sortase-Mediated Modification for Targeted Nanomedicine.
    Hashad RA; Lange JL; Tan NCW; Alt K; Hagemeyer CE
    Methods Mol Biol; 2019; 2033():67-80. PubMed ID: 31332748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-species reactivity of the anti-idiotype anti-OKT3 cascade between mice and humans.
    Carreno M; Fuller L; Zucker K; Yang WC; Burke G; Nery J; Gomez C; Esquenazi V; Miller J
    Hum Immunol; 1992 Apr; 33(4):249-58. PubMed ID: 1386353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monospecific bivalent scFv-SH: effects of linker length and location of an engineered cysteine on production, antigen binding activity and free SH accessibility.
    Albrecht H; Denardo GL; Denardo SJ
    J Immunol Methods; 2006 Mar; 310(1-2):100-16. PubMed ID: 16499921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant chimeric OKT3 scFv IgM antibodies mediate immune suppression while reducing T cell activation in vitro.
    Choi I; De Ines C; Kürschner T; Cochlovius B; Sörensen V; Olafsen T; Sandlie I; Little M
    Eur J Immunol; 2001 Jan; 31(1):94-106. PubMed ID: 11169443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and identification of recombinant soluble single-chain variable fragment of monoclonal antibody MC3.
    He FT; Nie YZ; Chen BJ; Qiao TD; Fan DM; Li RF; Kang YS; Zhang Y
    World J Gastroenterol; 2002 Apr; 8(2):258-62. PubMed ID: 11925603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic encoding and labeling of aliphatic azides and alkynes in recombinant proteins via a pyrrolysyl-tRNA Synthetase/tRNA(CUA) pair and click chemistry.
    Nguyen DP; Lusic H; Neumann H; Kapadnis PB; Deiters A; Chin JW
    J Am Chem Soc; 2009 Jul; 131(25):8720-1. PubMed ID: 19514718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NKG2D Ligand-Targeted Bispecific T-Cell Engagers Lead to Robust Antitumor Activity against Diverse Human Tumors.
    Godbersen C; Coupet TA; Huehls AM; Zhang T; Battles MB; Fisher JL; Ernstoff MS; Sentman CL
    Mol Cancer Ther; 2017 Jul; 16(7):1335-1346. PubMed ID: 28500232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interference of HCV replication by cell penetrable human monoclonal scFv specific to NS5B polymerase.
    Thueng-in K; Thanongsaksrikul J; Jittavisutthikul S; Seesuay W; Chulanetra M; Sakolvaree Y; Srimanote P; Chaicumpa W
    MAbs; 2014; 6(5):1327-39. PubMed ID: 25517317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Side-effects of a monoclonal antibody, muromonab CD3/orthoclone OKT3: bibliographic review.
    Sgro C
    Toxicology; 1995 Dec; 105(1):23-9. PubMed ID: 8638282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloning and sequencing of the VH and V kappa genes of an anti-CD3 monoclonal antibody, and construction of a mouse/human chimeric antibody.
    Arakawa F; Kuroki M; Kuwahara M; Senba T; Ozaki H; Matsuoka Y; Misumi Y; Kanda H; Watanabe T
    J Biochem; 1996 Sep; 120(3):657-62. PubMed ID: 8902633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ATTACK, a novel bispecific T cell-recruiting antibody with trivalent EGFR binding and monovalent CD3 binding for cancer immunotherapy.
    Harwood SL; Alvarez-Cienfuegos A; Nuñez-Prado N; Compte M; Hernández-Pérez S; Merino N; Bonet J; Navarro R; Van Bergen En Henegouwen PMP; Lykkemark S; Mikkelsen K; Mølgaard K; Jabs F; Sanz L; Blanco FJ; Roda-Navarro P; Alvarez-Vallina L
    Oncoimmunology; 2017; 7(1):e1377874. PubMed ID: 29296540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.